{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:56:33Z","timestamp":1794333393593,"version":"4.9.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-234"],"award-info":[{"award-number":["2022-PUMCH-A-234"]}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2017-I2M-1-002"],"award-info":[{"award-number":["2017-I2M-1-002"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2017-I2M-3-005"],"award-info":[{"award-number":["2017-I2M-3-005"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary benign metastasizing leiomyoma (PBML) is the most common extrauterine spread of uterine leiomyoma, and its biological behavior is traditionally thought to be hormone dependent. Studies on older PBML patients have been previously reported, but limited literature has been published regarding the clinical features and treatment of PBML in young women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 65 cases of PBML in women aged 45 years and younger were reviewed, including 56 cases selected from PubMed and 9 cases from our hospital. The clinical characteristics and management of these patients were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age of all the patients at diagnosis was 39.0 years. PBML most commonly presented as bilateral solid lesions (60.9%), with other rare imaging manifestations. The median interval time from a pertinent gynecologic procedure to diagnosis was 6.0 years. A total of 16.7% of patients received careful observation, and all achieved stable status in a median follow-up time of 18.0 months. A total of 71.4% of patients were administered anti-estrogen therapies, including surgical castration (33.3%), gonadotropin-releasing hormone analog (23.8%) and anti-estrogen drugs (14.3%). Eight of 42 patients underwent surgical resection of metastatic lesions. Patients who underwent curative surgery for the removal of pulmonary lesions combined with adjuvant anti-estrogen therapies had favorable outcomes compared with those who only underwent surgical resection. The disease control rates of surgical castration, gonadotropin-releasing hormone analog, and anti-estrogen drugs were 85.7%, 90.0%, and 50.0%, respectively. For two patients, sirolimus (rapamycin) achieved successful relief of symptoms and control of pulmonary lesions without lowering hormone levels and causing estrogen deficiency symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In the absence of standard treatment guidelines for PBML, maintaining a low-estrogen environment using different kinds of antiestrogen therapies has been the mainstream strategy and has satisfying curative effects. A wait-and-see strategy might be an option, but therapeutic approaches must be contemplated when complications or symptoms progress. For PBML in young women, the negative effect on ovarian function of anti-estrogen treatment, especially surgical castration, should be considered. Sirolimus might be a new treatment option for young PBML patients, especially for those who want to preserve ovarian function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-023-02406-7","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T10:41:23Z","timestamp":1684147283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pulmonary benign metastasizing leiomyoma in patients aged 45 years and younger: clinical features and novelty in treatment"],"prefix":"10.1186","volume":"23","author":[{"given":"Hao","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengzhi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"issue":"3","key":"2406_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccm.2016.04.019","volume":"37","author":"G Pacheco-Rodriguez","year":"2016","unstructured":"Pacheco-Rodriguez G, Taveira-DaSilva AM, Moss J. Benign Metastasizing Leiomyoma. Clin Chest Med. 2016;37(3):589\u201395.","journal-title":"Clin Chest Med"},{"issue":"1","key":"2406_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.athoracsur.2015.05.107","volume":"101","author":"J Miller","year":"2016","unstructured":"Miller J, Shoni M, Siegert C, Lebenthal A, Godleski J, McNamee C. Benign Metastasizing Leiomyomas to the lungs: an Institutional Case Series and a review of the recent literature. Ann Thorac Surg. 2016;101(1):253\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"2406_CR3","doi-asserted-by":"publisher","first-page":"e0175875","DOI":"10.1371\/journal.pone.0175875","volume":"12","author":"E Barna\u015b","year":"2017","unstructured":"Barna\u015b E, Ksi\u0105\u017cek M, Ra\u015b R, Skr\u0119t A, Skr\u0119t-Magier\u0142o J, Dmoch-Gajzlerska E. Benign metastasizing leiomyoma: a review of current literature in respect to the time and type of previous gynecological surgery. PLoS ONE. 2017;12(4):e0175875.","journal-title":"PLoS ONE"},{"issue":"2","key":"2406_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"issue":"5","key":"2406_CR5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jaad.2012.02.010","volume":"67","author":"AP Chen","year":"2012","unstructured":"Chen AP, Setser A, Anadkat MJ, et al. Grading dermatologic adverse events of cancer treatments: the common terminology criteria for adverse events Version 4.0. J Am Acad Dermatol. 2012;67(5):1025\u201339.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2406_CR6","first-page":"89","volume":"15","author":"PE Steiner","year":"1939","unstructured":"Steiner PE. Metastasizing fibroleiomyoma of the uterus: report of a case and review of the literature. Am J Pathol. 1939;15(1):89\u20131107.","journal-title":"Am J Pathol"},{"issue":"1","key":"2406_CR7","first-page":"1","volume":"1","author":"Y A\u011fa\u00e7kiran","year":"2014","unstructured":"A\u011fa\u00e7kiran Y, Findik G, Ust\u00fcn LN, Aydo\u011fdu K, Kaya S. Pulmonary Benign Metastasizing Leiomyoma: an extremely rare case. Turk Patoloji Derg. 2014;1(1):1\u20134.","journal-title":"Turk Patoloji Derg"},{"issue":"7","key":"2406_CR8","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1210\/jc.2003-032021","volume":"89","author":"JA Rivera","year":"2004","unstructured":"Rivera JA, Christopoulos S, Small D, Trifiro M. Hormonal manipulation of benign metastasizing leiomyomas: report of two cases and review of the literature. J Clin Endocrinol Metab. 2004;89(7):3183\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2406_CR9","doi-asserted-by":"publisher","first-page":"E672","DOI":"10.21037\/jtd.2016.06.61","volume":"8","author":"A Ottlakan","year":"2016","unstructured":"Ottlakan A, Borda B, Lazar G, Tiszlavicz L, Furak J. Treatment decision based on the biological behavior of pulmonary benign metastasizing leiomyoma. J Thorac Dis. 2016;8(8):E672\u20136.","journal-title":"J Thorac Dis"},{"issue":"8","key":"2406_CR10","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s12094-018-1847-y","volume":"20","author":"J Jiang","year":"2018","unstructured":"Jiang J, He M, Hu X, Ni C, Yang L. Deep sequencing reveals the molecular pathology characteristics between primary uterine leiomyoma and pulmonary benign metastasizing leiomyoma. Clin Transl Oncol. 2018;20(8):1080\u20136.","journal-title":"Clin Transl Oncol"},{"issue":"15suppl","key":"2406_CR11","doi-asserted-by":"publisher","first-page":"e22525","DOI":"10.1200\/JCO.2017.35.15_suppl.e22525","volume":"35","author":"APaoloD Vittoria Colia","year":"2017","unstructured":"Vittoria Colia APaoloD, Tos E, Fumagalli, et al. Benign metastasizing leiomyoma (BML): a retrospective case series analysis of 8 patients (pts). J Clin Oncol. 2017;35(15suppl):e22525.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2406_CR12","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1093\/oncolo\/oyab019","volume":"27","author":"J Boavida Ferreira","year":"2022","unstructured":"Boavida Ferreira J, Cabrera R, Santos F, et al. Benign Metastasizing Leiomyomatosis to the skin and lungs, intravenous leiomyomatosis, and leiomyomatosis Peritonealis Disseminata: a Series of five cases. Oncologist. 2022;27(1):e89\u201398.","journal-title":"Oncologist"},{"issue":"7","key":"2406_CR13","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.fertnstert.2016.09.018","volume":"106","author":"PM Sarrel","year":"2016","unstructured":"Sarrel PM, Sullivan SD, Nelson LM. Hormone replacement therapy in young women with surgical primary ovarian insufficiency. Fertil Steril. 2016;106(7):1580\u20137.","journal-title":"Fertil Steril"},{"issue":"1","key":"2406_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12890-020-01330-4","volume":"20","author":"R Fan","year":"2020","unstructured":"Fan R, Feng F, Yang H, et al. Pulmonary benign metastasizing leiomyomas: a case series of 23 patients at a single facility. BMC Pulm Med. 2020;20(1):292.","journal-title":"BMC Pulm Med"},{"issue":"5","key":"2406_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/humupd\/dmv030","volume":"21","author":"AE Commandeur","year":"2015","unstructured":"Commandeur AE, Styer AK, Teixeira JM. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update. 2015;21(5):593\u2013615.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"2406_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-0037-1599090","volume":"35","author":"MM McWilliams","year":"2017","unstructured":"McWilliams MM, Chennathukuzhi VM. Recent advances in uterine fibroid etiology. Semin Reprod Med. 2017;35(2):181\u20139.","journal-title":"Semin Reprod Med"},{"issue":"15","key":"2406_CR17","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1158\/0008-5472.CAN-08-4471","volume":"69","author":"JS Crabtree","year":"2009","unstructured":"Crabtree JS, Jelinsky SA, Harris HA, et al. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway. Cancer Res. 2009;69(15):6171\u20138.","journal-title":"Cancer Res"},{"issue":"1","key":"2406_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13023-019-1178-2","volume":"14","author":"S Hu","year":"2019","unstructured":"Hu S, Wu X, Xu W, et al. Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis. Orphanet J Rare Dis. 2019;14(1):206.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"2406_CR19","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/1471-0528.16156","volume":"127","author":"G Zhang","year":"2020","unstructured":"Zhang G, Feng F, Wang W, Zhu L. Rapamycin (sirolimus) in treatment of recurrent intravenous leiomyomatosis: a case report. BJOG. 2020;127(6):768\u201371.","journal-title":"BJOG"},{"issue":"10","key":"2406_CR20","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.7150\/thno.42869","volume":"10","author":"C Zhou","year":"2020","unstructured":"Zhou C, Liu C, Liu W, et al. SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway. Theranostics. 2020;10(10):4627\u201343.","journal-title":"Theranostics"},{"issue":"2","key":"2406_CR21","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3892\/etm.2014.2093","volume":"9","author":"G Yang","year":"2015","unstructured":"Yang G, Yang L, Yang X, et al. Efficacy and safety of a mammalian target of rapamycin inhibitor in pediatric patients with tuberous sclerosis complex: a systematic review and meta-analysis. Exp Ther Med. 2015;9(2):626\u201330.","journal-title":"Exp Ther Med"},{"issue":"1","key":"2406_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.gene.2013.03.039","volume":"523","author":"XM Zhang","year":"2013","unstructured":"Zhang XM, Li L, Xu JJ, et al. Rapamycin preserves the follicle pool reserve and prolongs the ovarian lifespan of female rats via modulating mTOR activation and sirtuin expression. Gene. 2013;523(1):82\u20137.","journal-title":"Gene"},{"issue":"21","key":"2406_CR23","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.4161\/cc.26578","volume":"12","author":"LL Luo","year":"2013","unstructured":"Luo LL, Xu JJ, Fu YC. Rapamycin prolongs female reproductive lifespan. Cell Cycle. 2013;12(21):3353\u20134.","journal-title":"Cell Cycle"},{"issue":"12","key":"2406_CR24","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.7150\/ijms.75203","volume":"19","author":"JY Park","year":"2022","unstructured":"Park JY, Chae B, Kim MR. The potential of transforming growth factor-beta inhibitor and vascular endothelial growth factor inhibitor as therapeutic agents for uterine leiomyoma. Int J Med Sci. 2022;19(12):1779\u201386.","journal-title":"Int J Med Sci"},{"key":"2406_CR25","doi-asserted-by":"publisher","first-page":"100903","DOI":"10.1016\/j.gore.2021.100903","volume":"39","author":"S Chhabra","year":"2021","unstructured":"Chhabra S, Sangani P, Saig R, Stany M. Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis. Gynecol Oncol Rep. 2021;39:100903.","journal-title":"Gynecol Oncol Rep"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02406-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02406-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02406-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T10:42:15Z","timestamp":1684147335000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02406-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2406"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02406-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2301258\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"assertion":[{"value":"22 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of Peking Union Medical College Hospital approved this research (approval number: S-K1117). The written informed consent from the 2 patients who participated in the clinical trial (NCT03500367) was previously obtained, while the rest of 7 patients\u2019 informed consent from our hospital was waived by the Institutional Review Board of Peking Union Medical College Hospital because the retrospective study\u2019s time span was large and some of these patients were hard to contact. The whole process of our study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflicts of interest and declare that we do not have any significant interest with commercial supporters.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}